Literature DB >> 29574670

Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis.

Iva Bozic1, Katarina Tesovic2, Danijela Laketa3, Marija Adzic3, Marija Jakovljevic2, Ivana Bjelobaba2, Danijela Savic2, Nadezda Nedeljkovic3, Sanja Pekovic2, Irena Lavrnja2.   

Abstract

Kv1.3 is a voltage gated potassium channel that has been implicated in pathophysiology of multiple sclerosis (MS). In the present study we investigated temporal and cellular expression pattern of this channel in the lumbar part of spinal cords of animals with experimental autoimmune encephalomyelitis (EAE), animal model of MS. EAE was actively induced in female Dark Agouti rats. Expression of Kv1.3 was analyzed at different time points of disease progression, at the onset, peak and end of EAE. We here show that Kv1.3 increased by several folds at the peak of EAE at both gene and protein level. Double immunofluorescence analyses demonstrated localization of Kv1.3 on activated microglia, macrophages, and reactive astrocytes around inflammatory lesions. In vitro experiments showed that pharmacological block of Kv1.3 in activated astrocytes suppresses the expression of proinflammatory mediators, suggesting a role of this channel in inflammation. Our results support the hypothesis that Kv1.3 may be a therapeutic target of interest for MS and add astrocytes to the list of cells whose activation would be suppressed by inhibiting Kv1.3 in inflammatory conditions.

Entities:  

Keywords:  Agitoxin-2; Astrocytes; Experimental autoimmune encephalomyelitis; Neuroinflammation; Voltage gated potassium channel Kv1.3

Mesh:

Substances:

Year:  2018        PMID: 29574670     DOI: 10.1007/s11064-018-2509-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  73 in total

1.  Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease.

Authors:  Srikant Rangaraju; Marla Gearing; Lee-Way Jin; Allan Levey
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 2.  Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.

Authors:  Ivana Bjelobaba; Danijela Savic; Irena Lavrnja
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

3.  The Kv1.3 potassium channel is localized to the cis-Golgi and Kv1.6 is localized to the endoplasmic reticulum in rat astrocytes.

Authors:  Jing Zhu; Jenny Yan; William B Thornhill
Journal:  FEBS J       Date:  2014-07-01       Impact factor: 5.542

4.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Bonnie N Dittel
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

5.  Potassium Channel Blockers Inhibit Adoptive Transfer of Experimental Allergic Encephalomyelitis by Myelin-Basic-Protein-Stimulated Rat T Lymphocytes.

Authors:  S.I.V. Judge; J.Z. Yeh; M.D. Mannie; L. Pope Seifert; P.Y. Paterson
Journal:  J Biomed Sci       Date:  1997 Jul-Aug       Impact factor: 8.410

6.  Autoantigen specific T cells inhibit glutamate uptake in astrocytes by decreasing expression of astrocytic glutamate transporter GLAST: a mechanism mediated by tumor necrosis factor-alpha.

Authors:  Thomas Korn; Tim Magnus; Stefan Jung
Journal:  FASEB J       Date:  2005-08-25       Impact factor: 5.191

7.  Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.

Authors:  Christine Beeton; Heike Wulff; Nathan E Standifer; Philippe Azam; Katherine M Mullen; Michael W Pennington; Aaron Kolski-Andreaco; Eric Wei; Alexandra Grino; Debra R Counts; Ping H Wang; Christine J LeeHealey; Brian S Andrews; Ananthakrishnan Sankaranarayanan; Daniel Homerick; Werner W Roeck; Jamshid Tehranzadeh; Kimber L Stanhope; Pavel Zimin; Peter J Havel; Stephen Griffey; Hans-Guenther Knaus; Gerald T Nepom; George A Gutman; Peter A Calabresi; K George Chandy
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

8.  Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.

Authors:  D R Huang; J Wang; P Kivisakk; B J Rollins; R M Ransohoff
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

9.  Controls for immunohistochemistry: the Histochemical Society's standards of practice for validation of immunohistochemical assays.

Authors:  Stephen M Hewitt; Denis G Baskin; Charles W Frevert; William L Stahl; Eduardo Rosa-Molinar
Journal:  J Histochem Cytochem       Date:  2014-07-14       Impact factor: 2.479

10.  Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1.

Authors:  André Quincozes-Santos; Larissa Daniele Bobermin; Alexandra Latini; Moacir Wajner; Diogo Onofre Souza; Carlos-Alberto Gonçalves; Carmem Gottfried
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more
  8 in total

1.  Modulation of pacemaker channel function in a model of thalamocortical hyperexcitability by demyelination and cytokines.

Authors:  Rahul Chaudhary; Stefanie Albrecht; Maia Datunashvili; Manuela Cerina; Annika Lüttjohann; Ye Han; Venu Narayanan; Dane M Chetkovich; Tobias Ruck; Tanja Kuhlmann; Hans-Christian Pape; Sven G Meuth; Mehrnoush Zobeiri; Thomas Budde
Journal:  Cereb Cortex       Date:  2022-10-08       Impact factor: 4.861

2.  The Potassium Channel Kv1.5 Expression Alters During Experimental Autoimmune Encephalomyelitis.

Authors:  I Bozic; D Savic; A Milosevic; M Janjic; D Laketa; K Tesovic; I Bjelobaba; M Jakovljevic; N Nedeljkovic; S Pekovic; I Lavrnja
Journal:  Neurochem Res       Date:  2019-10-17       Impact factor: 3.996

3.  Potassium Channels Kv1.3 and Kir2.1 But Not Kv1.5 Contribute to BV2 Cell Line and Primary Microglial Migration.

Authors:  Ruxandra Anton; Mihail Ghenghea; Violeta Ristoiu; Christophe Gattlen; Marc-Rene Suter; Petre Alexandru Cojocaru; Aurel Popa-Wagner; Bogdan Catalin; Alexandru-Florian Deftu
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

4.  Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's disease.

Authors:  Supriya Ramesha; Sruti Rayaprolu; Christine A Bowen; Cynthia R Giver; Sara Bitarafan; Hai M Nguyen; Tianwen Gao; Michael J Chen; Ngozi Nwabueze; Eric B Dammer; Amanda K Engstrom; Hailian Xiao; Andrea Pennati; Nicholas T Seyfried; David J Katz; Jacques Galipeau; Heike Wulff; Edmund K Waller; Levi B Wood; Allan I Levey; Srikant Rangaraju
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 12.779

Review 5.  Kv1.3 Channel as a Key Therapeutic Target for Neuroinflammatory Diseases: State of the Art and Beyond.

Authors:  Xiaoli Wang; Guoyi Li; Jingkang Guo; Zhiping Zhang; Shuzhang Zhang; Yudan Zhu; Jiwei Cheng; Lu Yu; Yonghua Ji; Jie Tao
Journal:  Front Neurosci       Date:  2020-01-14       Impact factor: 4.677

6.  Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis.

Authors:  Ioannis Markakis; Ioannis Charitakis; Christine Beeton; Melpomeni Galani; Elpida Repousi; Stella Aggeloglou; Petros P Sfikakis; Michael W Pennington; K George Chandy; Cornelia Poulopoulou
Journal:  Front Pharmacol       Date:  2021-09-23       Impact factor: 5.810

Review 7.  Astrocyte phenotypes: Emphasis on potential markers in neuroinflammation.

Authors:  Iva Bozic; Danijela Savic; Irena Lavrnja
Journal:  Histol Histopathol       Date:  2020-11-23       Impact factor: 2.303

8.  Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma.

Authors:  Alfonso Grimaldi; Giuseppina D'Alessandro; Maria Amalia Di Castro; Clotilde Lauro; Vikrant Singh; Francesca Pagani; Luigi Sforna; Francesca Grassi; Silvia Di Angelantonio; Luigi Catacuzzeno; Heike Wulff; Cristina Limatola; Myriam Catalano
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.